Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Actimed Therapeutics Ltd.
Headquarters: Ascot, Berkshire, United Kingdom
Website: https://actimedtherapeutics...
Year Founded: 2017
Status: Private
BioCentury | Jan 18, 2025
Management Tracks
Moves at FDA, NIH
Plus: updates on AZ, Actimed, Kailera, Nasus and more
BioCentury | Nov 15, 2024
Management Tracks
Howard Hechler named CEO of Lumicell
Plus: Veronica Fonck becomes chair of MinervaX, and updates from Grey Wolf, Actimed and Caszyme
BioCentury | Oct 21, 2023
Management Tracks
Daly to succeed McEnany as Catalyst CEO
Plus: Hennemand joins Covant as CEO and updates from Invitae, Immunome, Antiva, Omeros, Actimed and RegCell
BioCentury | Feb 3, 2021
Management Tracks
Lilly Asia’s Li joins AffaMed as president; plus moves at Actimed, Elicio, Life Biosciences, OncoNano, Tollys, HighTide and Patient Square Capital
China-based in-licensing company AffaMed Therapeutics (Shanghai) Co. Ltd. hired Ji Li as president. Li was most recently a venture partner at Lilly Asia Ventures, and prior to that
BioCentury | Nov 2, 2019
Company News
Management tracks: Genmab, Kintai, Aerie, Oasmia, Sangamo, Ovid, Checkmate, Third Pole, Actimed, IMV, Entasis, Rafael, Evaxion and Arvelle
Items per page:
1 - 5 of 5